CVS Health Corporation (NYSE:CVS) is considered one of the most undervalued large cap stocks to invest in now. Argus and Bank of America both recently lowered their price targets for CVS Health following a Medicare Advantage rate proposal for 2027. Despite potential revenue and margin headwinds, BofA remains optimistic about CVS Health’s future performance. The firm operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.

Read more at Yahoo Finance: Argus Trims CVS Health (CVS) PT to $90 Amid Medicare Advantage Rate Uncertainty